Postural Orthostatic Tachycardia Syndrome / Autonomic Nervous System Dysfunction

What It Is

Postural orthostatic tachycardia syndrome — POTS — is a condition in which the heart rate increases abnormally when a person moves from lying down to sitting or standing. The diagnostic threshold for adults is a heart rate increase of 30 beats per minute or more within ten minutes of standing, in the absence of a significant drop in blood pressure. The result is a cascade of symptoms — lightheadedness, palpitations, brain fog, fatigue, nausea, headache, and in some cases fainting — that are triggered or worsened by upright posture and relieved by lying down.

POTS is classified as a form of dysautonomia — dysfunction of the autonomic nervous system, the branch of the nervous system that regulates things we do not consciously control: heart rate, blood pressure, digestion, temperature regulation, and the automatic adjustments the body makes when we change position. It affects an estimated one to three million people in the United States. At least 80 percent of diagnosed patients are women. It frequently develops following a viral illness, surgery, trauma, or other significant physiological stressor.

Here is what most POTS explanations stop short of saying: POTS is not a single disease. It is a syndrome — a final common pathway with multiple possible upstream causes producing the same observable symptom picture. A 2026 Frontiers in Neurology review argued directly that the umbrella label dysautonomia is frequently applied imprecisely in POTS and is often interpreted — by clinicians and patients alike — as autonomic failure, when in many patients the dominant physiology is not autonomic failure at all but compensatory activation in response to orthostatic stress such as low central blood volume, venous pooling, or impaired vasoconstriction. Frontiers

In plain language: the autonomic nervous system is often doing exactly what it is supposed to do. It is compensating for a different problem. The tachycardia is not the disease. It is the alarm system going off because something else is wrong. Treating the alarm without finding what triggered it is not a solution.

The Three Primary Subtypes

Three primary POTS phenotypes are recognized — hyperadrenergic, neuropathic, and hypovolemic — each with different underlying mechanisms and each requiring different management approaches. There are currently no FDA-approved medications specifically for POTS. ScienceDirect

Neuropathic POTS involves peripheral sympathetic nerve damage — the small nerve fibers that regulate blood vessel constriction in the legs are not working correctly, allowing blood to pool in the lower body when standing. The heart races trying to compensate for inadequate venous return.

Hyperadrenergic POTS involves excessive norepinephrine release — the sympathetic nervous system is overactivated, producing high heart rate, high blood pressure on standing, anxiety-like symptoms, and significant tremor.

Hypovolemic POTS involves chronically low blood volume — the tank is not full enough to maintain adequate cerebral perfusion when gravity pulls blood downward. The heart races trying to move inadequate volume to where it is needed.

These mechanisms can coexist within the same patient, producing a heterogeneous symptom presentation ultimately defined by orthostatic intolerance. Cleveland Clinic Journal of Medicine Which is another way of saying: multiple broken systems can produce the same observable problem, and treating them identically because they look the same from the outside is not medicine. It is pattern matching.

The Plumbing Question Nobody Is Asking

This is the section that most POTS resources skip entirely.

Every explanation of POTS focuses on the wiring — the autonomic nervous system, the nerve fibers, the norepinephrine pathways, the reflex arcs. What very few explanations address is what happens when the plumbing itself is compromised before the wiring ever gets involved.

Humans are not elephants. Elephants have specialized vascular pads in their feet that actively assist venous return — pushing blood back up against gravity with each step. Human venous return depends on functional small vessel circulation, adequate blood viscosity, intact capillary beds, and a cardiovascular system that is not fighting compromised pipes just to keep the brain perfused when we stand up.

When triglycerides are elevated — significantly elevated, the way they get in someone with unmanaged hereditary fructose intolerance, unmanaged celiac disease, or metabolic syndrome running unchecked for years — the blood thickens. Small vessels that are supposed to constrict efficiently when we stand, redirecting blood flow to maintain cerebral perfusion, cannot do their job adequately through thick, lipid-laden blood. Capillary beds that should be delivering oxygen and nutrients to peripheral tissues are compromised. Venous return from the lower extremities becomes sluggish.

The autonomic nervous system responds the only way it knows how — it fires every compensation mechanism available. Heart rate climbs. Sympathetic activation increases. The alarm goes off. And someone hands the patient a POTS diagnosis without ever running a lipid panel.

Recent research has identified potential metabolic associations with POTS pathophysiology, particularly involving insulin resistance and abnormal vasoactive gut hormones — suggesting that the metabolic picture of a POTS patient deserves investigation alongside the autonomic picture. ScienceDirect

The mechanic's question is simple: before concluding the wiring is broken, check whether the pipes are clogged. Get a full lipid panel. Get the triglyceride number specifically. Understand what elevated triglycerides do to small vessel circulation, peripheral nerve function, and venous return. Ask about fenofibrate by name if the number is elevated. Statins do not treat triglycerides. Fenofibrate does. These are not the same medication treating the same problem.

If elevated triglycerides, NAFLD, or reactive hypoglycemia are part of the picture alongside orthostatic symptoms, hereditary fructose intolerance is worth considering as a possible upstream cause of the metabolic problem driving the circulatory compromise. See the HFI page in the Metabolic and Genetic section of the Medical Library.

Symptoms

POTS symptoms include lightheadedness — occasionally with fainting — difficulty thinking and concentrating, fatigue, exercise intolerance, headache, blurry vision, palpitations, tremor, and nausea. Symptoms worsen on standing and improve with lying down. Johns Hopkins Medicine

Additional features can include brain fog, sleep disruption, gastrointestinal symptoms including nausea and motility problems, bladder dysfunction, temperature dysregulation, and anxiety-like symptoms that are autonomic in origin rather than psychiatric.

The symptom picture overlaps substantially with ME/CFS, fibromyalgia, and MCAS. The vast majority of adolescents and young adults with ME/CFS have POTS or related forms of orthostatic intolerance — and the intensity of fatigue, exercise intolerance, and other symptoms is greater in those with both ME/CFS and POTS than in those with POTS alone. Johns Hopkins Medicine

The MCAS/POTS/hEDS Triad

POTS frequently clusters with two other conditions in a pattern recognized in the research literature: mast cell activation syndrome — MCAS — and hypermobile Ehlers-Danlos syndrome — hEDS. The three conditions share underlying connective tissue, immune, and autonomic dysfunction mechanisms and tend to appear together more often than chance would predict.

If orthostatic symptoms are accompanied by widespread allergic-type reactions, skin flushing, gastrointestinal instability, and joint hypermobility, this triad deserves evaluation rather than treating each condition in isolation. See the MCAS page in the Autoimmune and Inflammatory section of the Medical Library.

The ME/CFS Overlap

Positional symptoms are documented in ME/CFS independently of a formal POTS diagnosis. The post-exertional crash pattern of ME/CFS — in which exceeding the energy envelope produces worsening of all symptoms for days afterward — includes circulatory and autonomic components that can look like POTS on a bad day without meeting the formal diagnostic threshold on a good one.

The crash day picture in ME/CFS — the difference between how the body handles lying down versus sitting versus standing — may reflect genuine autonomic dysregulation, circulatory compromise from metabolic dysfunction, or both operating simultaneously. Separating them requires evaluation, not assumption.

Diagnosis

POTS is diagnosed using either a ten-minute standing test or a head-up tilt table test. The tilt table test is the gold standard — ask for it by name. Johns Hopkins Medicine The standing test requires measuring heart rate lying down and then at regular intervals for ten minutes of standing. A sustained increase of 30 beats per minute or more meets the diagnostic threshold.

Before the POTS label is applied, the differential should include: thyroid disease, anemia, adrenal insufficiency, diabetes, peripheral neuropathy from any cause including hypertriglyceridemia, medication effects, volume depletion, and structural cardiovascular problems. The broad and often non-specific signs and symptoms of POTS can mimic numerous other disease processes, and a complete history and physical examination to establish onset, chronicity, and medication use is imperative. NCBI

What You Can Do About It

Ask for the tilt table test by name if orthostatic symptoms are significant. Ask for a full lipid panel with triglycerides specifically discussed — not just flagged as a number. Ask what elevated triglycerides do to small vessel circulation and peripheral nerve function. Ask about fenofibrate specifically if triglycerides are elevated. Ask for a full thyroid panel. Ask about MCAS if the symptom picture includes widespread reactivity and the triad pattern is present.

First-line management for confirmed POTS includes increased fluid and salt intake, compression garments to reduce lower extremity blood pooling, gradual physical reconditioning in a monitored program, and positional strategies. Pharmacologic options exist for specific subtypes but no FDA-approved POTS medication currently exists — management is symptom-directed and subtype-specific.

Personal Note

POTS and dysautonomia were never formally evaluated in my diagnostic loop. I want to be honest about that upfront — this page is built on research, observation, and mechanic's logic, not personal diagnosis.

What I did experience on crash days was positional. The difference between lying down and sitting up and standing was not subtle. Something in the circulatory picture changed with position in ways that were not simply fatigue. Combined with the jello-like sputum with brown flecks I documented during the worst periods — which points toward possible pulmonary fluid dynamics and positional circulation issues rather than classic respiratory disease — there are unanswered questions in my own picture that no physician ever formally investigated.

My mechanic's hypothesis, which I hold as an open question rather than a conclusion: how much of what gets labeled POTS in the ME/CFS and chronic illness population is actually circulatory compromise from hypertriglyceridemia — thick blood struggling through damaged small vessels, the heart racing to compensate, the autonomic nervous system firing every alarm it has because the plumbing is clogged — rather than primary autonomic nervous system dysfunction?

I spent years in ME/CFS, long COVID, and celiac support communities. I asked about triglycerides consistently. Not once did I find someone whose physician had checked the number, explained what it meant for circulation and nerve function, and offered fenofibrate and diet change as a treatment option.

I also noticed something that I want to say plainly and with compassion rather than judgment: a significant proportion of the people in those communities carrying POTS diagnoses were significantly overweight. Not as a moral observation — as a mechanical one.

Obesity is a major independent risk factor for hypertriglyceridemia. Hypertriglyceridemia compromises small vessel circulation. Compromised small vessel circulation makes venous return harder. Harder venous return means the cardiovascular system has to work harder against gravity every time a person stands up. The heart rate climbs. The autonomic system compensates. The symptoms of orthostatic intolerance appear.

And frequently — the weight itself is not a character failure. It is the downstream result of the same undiagnosed metabolic upstream causes — unmanaged celiac disease, unmanaged HFI, insulin resistance, metabolic syndrome running unchecked for years — that are producing the rest of the symptom picture. The person got heavy because the engine was running on the wrong fuel for decades before anyone found the answer. But the mechanical reality of what that weight does to circulatory dynamics when standing up is not optional physics.

Humans are not elephants. We do not have vascular pads in our feet designed to push blood back up against gravity. We depend on functional circulation, adequate blood viscosity, and pipes that are not compromised by years of metabolic damage. When the pipes are clogged and the blood is thick and gravity is working against a cardiovascular system already running on empty — the alarm goes off.

Check the triglycerides. Open the hood before you accept that the wiring is broken.

Nobody asked me about triglycerides during the years I was in that level of circulatory compromise. I am asking on behalf of everyone who hasn't been asked yet.

I'm not a doctor. I'm not telling you to change your medication. Everything here is personal testimony and links to real medical sources. Always work with a qualified physician.

Sources

• Frontiers in Neurology, 2026. "Postural orthostatic tachycardia syndrome: when dysautonomia misleads — a mechanistic argument for compensatory orthostatic tachycardia." PubMed.

• StatPearls/NCBI. "Postural Orthostatic Tachycardia Syndrome." Updated 2023. NCBI Bookshelf.

• Johns Hopkins Medicine. "Postural Orthostatic Tachycardia Syndrome (POTS)." hopkinsmedicine.org.

• Cleveland Clinic Journal of Medicine. "Autoimmunity and postural orthostatic tachycardia syndrome." 2023. PubMed.

• ScienceDirect. "Pathophysiology and management of postural orthostatic tachycardia syndrome: A literature review." 2024.

• ScienceDirect. "Metabolic targets in the Postural Orthostatic Tachycardia Syndrome." 2024.

• Kaseem M, et al. "Hypertriglyceridemia and peripheral neuropathy in neurologically asymptomatic patients." PubMed, 2006.

• Batchelor P. "Polyradiculopathy secondary to severe hypertriglyceridemia." BMJ Case Reports, 2015. PMC.